M

Madrigal Pharmaceuticals

95 employees

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Metabolic Disease

Biopharma

Medical Device

NASH

Liver Disease

2016

$100M

from 2 investors over 2 rounds

M

Madrigal Pharmaceuticals raised $100M on May 9, 2022

Investors: Hercules Capital, Inc.

M

Madrigal Pharmaceuticals raised undisclosed on April 1, 2014

Investors: Bay City Capital